Source: International Congress 2018 – Important changes in the management of tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
D. Cirillo (Milano (MI), Italy). When will genetic testing replace standard drug susceptibility testing?. International Congress 2018 – Important changes in the management of tuberculosis

Member's Comments

No comment yet.

Related content which might interest you: Modern molecular direct tests for rapid identification and drug susceptibility testing of Mycobacterium tuberculosis Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis Year: 2012 Bedaquiline: 10?years later, the drug susceptibility testing protocol is still pending Source: Eur Respir J 2015; 45: 317-321 Year: 2015 Drug-susceptibility testing in tuberculosis: methods and reliability of results Source: Eur Respir J 2005; 25: 564-569 Year: 2005 Comparison of rapid in-house methods for drug susceptibility testing of mycobacterium tuberculosis with gold standards Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis Year: 2007 The impact and cost-effectiveness of strategies to detect drug-resistant tuberculosis Source: Eur Respir J 2012; 39: 626-634 Year: 2012 Conversion of tuberculosis screening tests during biological therapy in patients with rheumatic diseases: what’s beyond screening values? Source: International Congress 2018 – Tuberculosis transmission and screening strategies Year: 2018 Pharmacokinetics and drug susceptibility testing imply limited activity of current regimens for Mycobacterium avium complex disease Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012 A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis Source: Eur Respir J, 50 (6) 1701354; 10.1183/13993003.01354-2017 Year: 2017 Treatment efficacy of MDR TB based on drug susceptibility testing with microchip technology Source: Eur Respir J 2002; 20: Suppl. 38, 566s Year: 2002 Advances in the diagnosis of mycobacteria infections and challenges of drug susceptibility testing Source: International Congress 2019 – New guidelines for treatment of nontuberculous mycobacterial pulmonary disease Year: 2019 Individual susceptibility to environmental risks Source: Annual Congress 2007 - Individual susceptibility to environmental risks Year: 2007 Systematic evaluation of clarithromycin (CLA) resistance associated mutations in Mycobacterium abscessus complex based on whole-genome sequencing analysis and drug susceptibility testing. Source: Virtual Congress 2020 – Translational science in respiratory infections Year: 2020 Are in vitro sensitivity tests for tuberculosis drugs a good guide of clinical outcome? Source: Annual Congress 2006 - The management of multidrug-resistant tuberculosis (MDRTB) on an individual and national level Year: 2006 Genotypic and phenotypic M. tuberculosis resistance: guiding clinicians to prescribe the correct regimens Source: Eur Respir J, 50 (6) 1702292; 10.1183/13993003.02292-2017 Year: 2017 Evaluation the drug susceptibility testing and the prevalence of resistance to antituberculosis drugs in a chronic department Source: Eur Respir J 2003; 22: Suppl. 45, 520s Year: 2003 Availability of drug susceptibility testing to new/re-purposed anti-tuberculosis drugs: a TBnet study Source: Virtual Congress 2021 – Advances in the diagnosis of tuberculosis, multidrug-resistant tuberculosis and nontuberculous mycobacterial disease Year: 2021 Evaluation of two computer screen tests for self lung function testing Source: Eur Respir J 2004; 24: Suppl. 48, 403s Year: 2004 First experience with novel molecular diagnostic method for detection of M. tuberculosis and rifampicin resistance Source: Annual Congress 2011 - Tuberculosis: from bench to bedside Year: 2011 Second-line anti-tuberculosis drug concentrations for susceptibility testing in the MODS assay Source: Eur Respir J 2013; 41: 1163-1171 Year: 2013